Recombinant human Interferon beta protein (Active)
- Bioactive
- What is this?
Be the first to review this product! Submit a review
|
(7 Publications)
Recombinant human Interferon beta protein (Active) is a Human Full Length protein, in the 22 to 187 aa range, expressed in CHO cells, with >95%, < 1 EU/µg endotoxin level, suitable for FuncS, HPLC, SDS-PAGE.
View Alternative Names
IFB, IFNB, IFNB1, Interferon beta, IFN-beta, Fibroblast interferon
Reactivity data
Sequence info
Properties and storage information
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Interferon beta functions as an important mediator of immune functions regulating the activity of natural killer cells and macrophages. It also boosts antigen presentation to T cells. Interferon beta belongs to the larger family of interferons which includes IFN-alpha and IFN-gamma each having distinct effects but working together to mount an effective immune response. Though it does not form part of a complex it plays a critical standalone role in immune signaling pathways.
Pathways
Interferon beta associates strongly with the JAK-STAT signaling pathway. Upon activation it interacts with receptors to phosphorylate STAT proteins mainly STAT1 and STAT2 which then dimerize and translocate to the nucleus to trigger gene expression. Another important pathway is the antiviral response where interferon beta modulates the expression of hundreds of interferon-stimulated genes. These pathways intricately involve other proteins like IFN-alpha and IFN-gamma which work synergistically to establish an effective antiviral environment.
Specifications
Form
Lyophilized
Additional notes
>= 95% HPLC analyses. Due to glycosylation, IFN-Β has an approximate MW of 22.3 kDa based on SDS-PAGE gel
General info
Function
Type I interferon cytokine that plays a key role in the innate immune response to infection, developing tumors and other inflammatory stimuli (PubMed : 10049744, PubMed : 10556041, PubMed : 6157094, PubMed : 6171735, PubMed : 7665574, PubMed : 8027027, PubMed : 8969169). Signals via binding to high-affinity (IFNAR2) and low-affinity (IFNAR1) heterodimeric receptor, activating the canonical Jak-STAT signaling pathway resulting in transcriptional activation or repression of interferon-regulated genes that encode the effectors of the interferon response, such as antiviral proteins, regulators of cell proliferation and differentiation, and immunoregulatory proteins (PubMed : 10049744, PubMed : 10556041, PubMed : 7665574, PubMed : 8027027, PubMed : 8969169). Signals mostly via binding to a IFNAR1-IFNAR2 heterodimeric receptor, but can also function with IFNAR1 alone and independently of Jak-STAT pathways (By similarity). Elicits a wide variety of responses, including antiviral and antibacterial activities, and can regulate the development of B-cells, myelopoiesis and lipopolysaccharide (LPS)-inducible production of tumor necrosis factor (By similarity). Plays a role in neuronal homeostasis by regulating dopamine turnover and protecting dopaminergic neurons : acts by promoting neuronal autophagy and alpha-synuclein clearance, thereby preventing dopaminergic neuron loss (By similarity). IFNB1 is more potent than interferon-alpha (IFN-alpha) in inducing the apoptotic and antiproliferative pathways required for control of tumor cell growth (By similarity).
Sequence similarities
Belongs to the type-I (or alpha/beta) interferon family.
Target data
Publications (7)
Recent publications for all applications. Explore the full list and refine your search
Viruses 17: PubMed40573387
2025
Applications
Unspecified application
Species
Unspecified reactive species
PLoS biology 22:e3002709 PubMed39012844
2024
Applications
Unspecified application
Species
Unspecified reactive species
British journal of cancer 129:1852-1862 PubMed37838813
2023
Applications
Unspecified application
Species
Unspecified reactive species
The EMBO journal 42:e110597 PubMed36912165
2023
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of biological chemistry 298:102698 PubMed36379255
2022
Applications
Unspecified application
Species
Unspecified reactive species
Pharmaceutical research 40:927-935 PubMed36163411
2022
Applications
Unspecified application
Species
Unspecified reactive species
The FEBS journal 289:808-831 PubMed34528388
2021
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com